The Association Between Anti‐insulin Aspart Antibodies and the Pharmacokinetic and Pharmacodynamic Characteristics of Fast‐acting Insulin Aspart in Children and Adolescents With Type 1 Diabetes

Pediatric Diabetes - United Kingdom
doi 10.1111/pedi.13026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Faster-Acting Insulin Aspart Provides Faster Onset and Greater Early Exposure vs Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

Pediatric Diabetes
Internal MedicinePediatricsEndocrinologyPerinatologyChild HealthMetabolismDiabetes
2017English

A Survey of Physician Experience and Treatment Satisfaction Using Fast-Acting Insulin Aspart in People With Type 1 or Type 2 Diabetes

Postgraduate Medicine
Medicine
2020English

Use of Fast‐acting Insulin Aspart in Insulin Pump Therapy in Clinical Practice

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Use of Short-Acting Insulin Aspart in Managing Older People With Diabetes

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2009English

Fiasp: A New Faster-Acting Insulin Aspart Formulation for Diabetes

Prescriber
Pharmacology
2017English

Comparison of a Soluble Co-Formulation of Insulin Degludec/Insulin Aspart vs Biphasic Insulin Aspart 30 in Type 2 Diabetes: A Randomised Trial

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2012English

Safety, Immunogenicity and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People With Diabetes Also Using Insulin Glargine: 12-Month Results From the GEMELLI 1 Trial

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2020English

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Efficacy and Safety of Fast-Acting Insulin Aspart in People With Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy